Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Disease Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04636814
What this trial is testing

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 3,973
Not applicableUnknownNCT05406934
What this trial is testing

Evaluation of Blood Platelet Indices,Platelet Aggregation in the Activity of IBD Patients on Biological Treatment

Who this might be right for
Bowel DiseaseInflammatory Bowel Diseases
Assiut University 120
Testing effectiveness (Phase 2)Ended earlyNCT05672199
What this trial is testing

Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Amgen 25
Testing effectiveness (Phase 2)Study completedNCT02986321
What this trial is testing

A 24-wk Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of a New PDE4 Inhibitor in Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 1,130
Large-scale testing (Phase 3)Active Not RecruitingNCT05782907
What this trial is testing

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
AbbVie 122
Post-approval studies (Phase 4)Study completedNCT05029921
What this trial is testing

Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 182
Post-approval studies (Phase 4)WithdrawnNCT02760615
What this trial is testing

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

Who this might be right for
Colitis, UlcerativeCrohn Disease
Takeda
Large-scale testing (Phase 3)Ended earlyNCT03467958
What this trial is testing

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Celgene 854
Early research (Phase 1)Study completedNCT00928681
What this trial is testing

Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Pfizer 80
Testing effectiveness (Phase 2)Ended earlyNCT04130919
What this trial is testing

Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Gilead Sciences 19
Post-approval studies (Phase 4)Active Not RecruitingNCT05879419
What this trial is testing

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondylitis, AnkylosingSpondyloarthritis+8 more
University of Sao Paulo General Hospital 2,005
Large-scale testing (Phase 3)Study completedNCT03945019
What this trial is testing

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)

Who this might be right for
Crohn's Disease
Celltrion 396
Testing effectiveness (Phase 2)Ended earlyNCT03893565
What this trial is testing

Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
GlaxoSmithKline 104
Not applicableStudy completedNCT05815355
What this trial is testing

Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease

Who this might be right for
Crohn's Disease
Sixth Affiliated Hospital, Sun Yat-sen University 48
Not applicableEnded earlyNCT00936585
What this trial is testing

NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease

Who this might be right for
ColitisCrohn's DiseaseInflammatory Bowel Disease
National Institutes of Health Clinical Center (CC) 2
Not applicableStudy completedNCT03534427
What this trial is testing

The Effects of a Jump Rope Exercise Program on Vascular Health, Inflammatory Markers in Prehypertensive Adolescent Girls

Who this might be right for
PrehypertensionBlood PressureAbdominal Obesity+1 more
Pusan National University 40
Not applicableStudy completedNCT04294615
What this trial is testing

Clinical Response and Safety Following FMT for UC

Who this might be right for
Inflammatory Bowel DiseasesFecal Microbiota Transplantation
Air Force Military Medical University, China 9
Not applicableStudy completedNCT03644355
What this trial is testing

Asthma and Obesity Diet Versus Exercise

Who this might be right for
Obesity, ChildhoodAsthma in ChildrenInflammatory Response+7 more
Louisiana State University Health Sciences Center in New Orleans 110
Large-scale testing (Phase 3)Study completedNCT01514240
What this trial is testing

Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan

Who this might be right for
Crohn's Disease
AstraZeneca 123
Early research (Phase 1)WithdrawnNCT02249078
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 3 Subcutaneous and 1 Intravenous Dose of E6011 in Subjects With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Eisai Inc.
Next Page